Related Experiment Video

Updated: Sep 30, 2025

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

17.5K

Arrhythmogenic Cardiomyopathy as a Late Complication of COVID-19-Induced Myocarditis

David Campoamor1, Rui Seixas2, Leonor Gama3

  • 1Internal Medicine, Unidade Local de Saúde do Litoral Alentejano, Santiago do Cacém, PRT.

Cureus
|March 11, 2022
PubMed

Insights

This study details a rare case of inflammatory cardiomyopathy, a type of arrhythmogenic cardiomyopathy, occurring 40 days after a COVID-19 diagnosis. This highlights potential long-term cardiovascular complications of COVID-19 infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathology

Background:

  • COVID-19 (Coronavirus Disease 2019) is a global pandemic primarily causing respiratory illness.
  • Cardiovascular complications, including myocardial injury, are observed in a subset of COVID-19 patients.
  • Myocarditis has been reported as a potential complication of COVID-19.

Observation:

  • A case of inflammatory cardiomyopathy, a form of arrhythmogenic cardiomyopathy, is presented.
  • The patient was a 32-year-old male diagnosed with COVID-19.
  • The cardiomyopathy was diagnosed 40 days post-COVID-19 infection.

Findings:

  • The case illustrates a distinct cardiac pathology following COVID-19, differing from typical myocarditis.
  • Inflammatory cardiomyopathy represents a significant, albeit rare, cardiovascular sequela of SARS-CoV-2 infection.
  • This case expands the spectrum of known COVID-19-associated cardiac conditions.

Implications:

  • Further research is needed to understand the mechanisms linking COVID-19 to inflammatory cardiomyopathy.
  • Clinicians should consider inflammatory cardiomyopathy in patients with cardiac symptoms post-COVID-19.
  • This finding underscores the importance of monitoring cardiovascular health in individuals recovering from COVID-19.

Keywords:
arrhythmogenic cardiomyopathycovid-19covid-induced myocarditisinflammatory cardiomyopathyventricular arrhythmia

More Related Videos

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.4K
Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction08:31

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction

Published on: July 26, 2018

10.3K

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
96
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
68
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
36
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
46